Pneumococcal vaccination in splenectomised cancer patients

Although pneumococcal vaccination has been recommended in splenectomised patients for more than 30 years, its use remains unsatisfactory. We conducted two consecutive retrospective assessments to determine the rate of pneumococcal vaccination among splenectomised cancer patients at a single institut...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2005-08, Vol.41 (12), p.1731-1734
Main Authors: Omlin, Aurelius G., Mühlemann, Kathrin, Fey, Martin F., Pabst, Thomas
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Cancer
Female
Hodgkin Disease - complications
Hodgkin lymphoma
Humans
Male
Medical sciences
Middle Aged
Neoplasms - complications
Pharmacology. Drug treatments
Pneumococcal
Pneumococcal Infections - prevention & control
Pneumococcal Vaccines
Splenectomy
Splenectomy - adverse effects
Streptococcus pneumoniae
Tumors
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although pneumococcal vaccination has been recommended in splenectomised patients for more than 30 years, its use remains unsatisfactory. We conducted two consecutive retrospective assessments to determine the rate of pneumococcal vaccination among splenectomised cancer patients at a single institution. We found that 75% (82 of 115) of splenectomised cancer patients had received at least one documented pneumococcal vaccination as compared to only 59.7% of patients identified in a previous assessment conducted 1997. 20% (22 of 115) of the patients had not been vaccinated at all. Splenectomy was performed in 54% because of Hodgkin lymphoma. The pneumococcal vaccination coverage in this subgroup has risen from 40% in the previous assessment (1997) to 93% in the current survey. In conclusion, patients splenectomised at a young age because of Hodgkin lymphoma are the key group at risk for insufficient pneumococcal vaccination. Repeated assessments of the pneumococcal vaccination status increased the rate of vaccination.
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2005.04.027